Interestingly, while SEMA7A is known to affect monocyte activation in vitro via β 1 integrin–mediated effects (Holmes et al., 2002), the role of SEMA7A in the activation of tumor cells has not yet been studied. This evidence concerns the gene SEMA7A and neoplasm.